Abstract
Drug induced complication are becoming increasingly common in CF. In this review we discuss some of the key issues relating to drug side in an ageing population of patients with CF. Strategies to reduce drug complications are also discussed.
Copyright © 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
MeSH terms
-
Administration, Inhalation
-
Adrenal Cortex Hormones / administration & dosage
-
Adrenal Cortex Hormones / adverse effects
-
Aminoglycosides / administration & dosage
-
Aminoglycosides / adverse effects
-
Anti-Bacterial Agents / administration & dosage
-
Anti-Bacterial Agents / adverse effects
-
Comorbidity
-
Coronary Disease / epidemiology
-
Cystic Fibrosis / complications
-
Cystic Fibrosis / drug therapy*
-
Cystic Fibrosis / epidemiology
-
Cystic Fibrosis / microbiology
-
Diabetes Complications / drug therapy
-
Diabetes Mellitus / epidemiology
-
Disease Progression
-
Drug Hypersensitivity / etiology
-
Exocrine Pancreatic Insufficiency / drug therapy
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Intestines / microbiology
-
Magnetic Resonance Imaging
-
Microbiota / drug effects
-
Patient Compliance
-
Piperacillin / administration & dosage
-
Piperacillin / adverse effects
Substances
-
Adrenal Cortex Hormones
-
Aminoglycosides
-
Anti-Bacterial Agents
-
Hypoglycemic Agents
-
Piperacillin